Relmada Therapeutics

RLMD

Market cap $455M

Buy

Hold

Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$10.33

66% upside

High target

positive

0 neutral

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Lucid Capital Markets Christopher Liu 100% 1-yr RLMD win rate				2 Mar ‘26 16 days ago
Leerink Partners Andrew Berens 100% 1-yr RLMD win rate				23 Jan ‘26 1 month ago
Jefferies Farzin Haque 100% 1-yr RLMD win rate				22 Dec ‘25 2 months ago